Autophagy induced by PP121 alleviates MSU crystal-induced acute gouty arthritis via inhibition of the NLRP3 inflammasome. 2023

Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
School of Clinical Medicine & The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China. Electronic address: 18000516795@163.com.

Acute gouty arthritis (AGA) is a frequent self-limiting inflammatory condition produced by the deposition of monosodium urate (MSU) crystals in the joints and periarticular tissues of patients with hyperuricemia. However, no effective interventional measures currently exist for AGA. Pyroptosis, a kind of pro-inflammatory programmed cell death, plays a crucial role in MSU crystal-induced inflammation and represents a potential treatment target for AGA. Therefore, we determined the therapeutic benefits and mechanism of PP121, a pyroptosis-related compound, on AGA. First, we injected an MSU crystal solution intra-articularly into the left foot pad of C57BL/6 mice to create an AGA mouse model. Subsequent treatment with PP121 substantially decreased tissue damage, pro-inflammatory cytokine release, and inflammatory cell infiltration caused by MSU crystals in the ankle joint. Consistent with these observations, the beneficial effects of PP121 on AGA were cancelled in Beclin1+/-(Becn1+/-) mice. Furthermore, after PP121 treatment, super-resolution microscopy revealed a strong relationship between lysosome-connected membrane protein/light chain 3 positive vesicles and the nucleotide-binding domain of leucine-rich family pyrin domain-containing 3 (NLPR3), demonstrating that PP121 promotes phagocytosis of the NLPR3 inflammasome. In summary, PP121-mediated autophagy can improve degradation of the NLRR3 inflammasome in AGA, which suggests the therapeutic potential of PP121 in AGA.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071199 NLR Family, Pyrin Domain-Containing 3 Protein An NLR protein that contains an N-terminal PYRIN DOMAIN and ATP-binding site and 9 C-terminal LEUCINE-rich repeats; it is expressed primarily by MACROPHAGES. It is a core component of the INFLAMMASOME and directs its assembly in response to pathogen infection and damage-associated stimuli. Mutations in the NLRP3 gene are associated with FAMILIAL COLD AUTOINFLAMMATORY SYNDROME. Cold Autoinflammatory Syndrome 1 Protein,NACHT, LRR and PYD Domains-Containing Protein 3,NLRP3 Protein,NACHT, LRR and PYD Domains Containing Protein 3,NLR Family, Pyrin Domain Containing 3 Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid
D015210 Arthritis, Gouty Arthritis, especially of the great toe, as a result of gout. Acute gouty arthritis often is precipitated by trauma, infection, surgery, etc. The initial attacks are usually monoarticular but later attacks are often polyarticular. Acute and chronic gouty arthritis are associated with accumulation of MONOSODIUM URATE in and around affected joints. Gouty Arthritis,Arthritides, Gouty,Gouty Arthritides
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D058847 Inflammasomes Multiprotein complexes that mediate the activation of CASPASE-1. Dysregulation of inflammasomes has also been linked to a number of autoinflammatory and autoimmune disorders. Inflammasome,Pyroptosome,Pyroptosomes

Related Publications

Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
November 2021, International immunopharmacology,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
April 2021, International immunopharmacology,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
January 2022, Journal of natural medicines,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
January 2021, Frontiers in pharmacology,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
February 2024, Alternative therapies in health and medicine,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
January 2023, European review for medical and pharmacological sciences,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
January 2019, Journal of biological regulators and homeostatic agents,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
December 2016, Autophagy,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
January 2021, Life sciences,
Wei Yuan, and Teng Liu, and Yuan-Yi Wang, and Shuang He, and Feng Zhang, and Xiao-Bian Wang, and Shi-Hua Deng, and Ting Zhang, and Dong-Ming Wu, and Ying Xu
January 2021, Frontiers in medicine,
Copied contents to your clipboard!